The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Economic Costs of Diabetes in the U.S. in 2012
Open accessAbstract
OBJECTIVE: This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2012. RESEARCH DESIGN AND METHODS: The study uses a prevalence-based approach that combines the demographics of the U.S. population in 2012 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, race/ethnicity, insurance coverage, medical condition, and health service category. Data sources include national surveys, Medicare standard analytical files, and one of the largest claims databases for the commercially insured population in the U.S. RESULTS: The total estimated cost of diagnosed diabetes in 2012 is $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity. The largest components of medical expenditures are hospital inpatient care (43% of the total medical cost), prescription medications to treat the complications of diabetes (18%), antidiabetic agents and diabetes supplies (12%), physician office visits (9%), and nursing/residential facility stays (8%). People with diagnosed diabetes incur average medical expenditures of about $13,700 per year, of which about $7,900 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures approximately 2.3 times higher than what expenditures would be in the absence of diabetes. For the cost categories analyzed, care for people with diagnosed diabetes accounts for more than 1 in 5 health care dollars in the U.S., and more than half of that expenditure is directly attributable to diabetes. Indirect costs include increased absenteeism ($5 billion) and reduced productivity while at work ($20.8 billion) for the employed population, reduced productivity for those not in the labor force ($2.7 billion), inability to work as a result of disease-related disability ($21.6 billion), and lost productive capacity due to early mortality ($18.5 billion). CONCLUSIONS: The estimated total economic cost of diagnosed diabetes in 2012 is $245 billion, a 41% increase from our previous estimate of $174 billion (in 2007 dollars). This estimate highlights the substantial burden that diabetes imposes on society. Additional components of societal burden omitted from our study include intangibles from pain and suffering, resources from care provided by nonpaid caregivers, and the burden associated with undiagnosed diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Self-citationEconomic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Self-citationBoyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309
Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.005 · Cited by 1,234
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Egede, L. E., Zheng, D., & Simpson, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.464 · Cited by 816
Impact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602
Deaths: preliminary data for 2011.
Hoyert, D. L., & Xu, J. (2012) · PubMed · Cited by 548
A review of adjusted estimators of attributable risk
Benichou, J. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000303 · Cited by 440
Health and Productivity as a Business Strategy: A Multiemployer Study
Loeppke, R., Taitel, M., Haufle, V., Parry, T., Kessler, R. C., & Jinnett, K. (2009) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e3181a39180 · Cited by 352
The Economic Burden Of Diabetes
Dall, T. M., Zhang, Y., Chen, Y. J., Quick, W. W., Yang, W. G., & Fogli, J. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0155 · Cited by 319
Lamb, C. E., Ratner, P. H., Johnson, C. E., Ambegaonkar, A. J., Joshi, A. V., Day, D., Sampson, N., & Eng, B. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112552 · Cited by 288
The Progressive Cost of Complications in Type 2 Diabetes Mellitus
Brown, J. B., Pedula, K. L., & Bakst, A. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1873 · Cited by 217
National Health Spending In 2004: Recent Slowdown Led By Prescription Drug Spending
Smith, C., Cowan, C., Heffler, S., & Catlin, A. (2006) · Health Affairs · doi:10.1377/hlthaff.25.1.186 · Cited by 163
Health Spending Projections Through 2016: Modest Changes Obscure Part D's Impact
Poisal, J. A., Truffer, C. J., Smith, S. D., Sisko, A. M., Cowan, C. A., Keehan, S. P., Dickensheets, B. A., & the National Health Expenditure Accounts Projections Team (2007) · Health Affairs · doi:10.1377/hlthaff.26.2.w242 · Cited by 153
Burden of Hospitalizations Primarily Due to Uncontrolled Diabetes
Kim, S. W. (2007) · Diabetes Care · doi:10.2337/dc06-2070 · Cited by 145
75 years of mortality in the United States, 1935-2010.
Hoyert, D. L. (2012) · PubMed · Cited by 113
The Economic Costs of Undiagnosed Diabetes
Zhang, Y., Dall, T. M., Mann, S. E., Chen, Y., Martin, J., Moore, V., Baldwin, A., Reidel, V. A., & Quick, W. W. (2009) · Population Health Management · doi:10.1089/pop.2009.12202 · Cited by 95
Prevalence of Diabetes and the Burden of Comorbid Conditions Among Elderly Nursing Home Residents
Dybicz, S. B., Thompson, S., Molotsky, S., & Stuart, B. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.05.001 · Cited by 91
Fu, A. Z., Qiu, Y., Radican, L., & Wells, B. J. (2009) · Diabetes Care · doi:10.2337/dc09-1128 · Cited by 89
Rodbard, H., Fox, K., & Grandy, S. (2009) · American Journal of Health Promotion · doi:10.4278/ajhp.081010-quan-243 · Cited by 84
Diabetes and Coronary Heart Disease as Risk Factors for Mortality in Older Adults
Carnethon, M. R., Biggs, M. L., Barzilay, J., Kuller, L. H., Mozaffarian, D., Mukamal, K., Smith, N. L., & Siscovick, D. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.11.023 · Cited by 77
Medical Cost Associated with Prediabetes
Zhang, Y., Dall, T. M., Chen, Y., Baldwin, A., Yang, W., Mann, S., Moore, V., Nestour, E. L., & Quick, W. W. (2009) · Population Health Management · doi:10.1089/pop.2009.12302 · Cited by 71
Direct and indirect costs among employees with diabetic retinopathy in the United States
Lee, L. J., Yu, A. P., Cahill, K. E., Oglesby, A. K., Tang, J., Qiu, Y., & Birnbaum, H. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x297303 · Cited by 67
The Association of Diabetes With Job Absenteeism Costs Among Obese and Morbidly Obese Workers
Cawley, J., Rizzo, J. A., & Haas, K. (2008) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31816ed029 · Cited by 31
DiBonaventura, M., Link, C. R., Pollack, M. F., Wagner, J.-S., & Williams, S. A. (2011) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e318209e0ce · Cited by 22
Research works printed but not linked: 1
- Paris, 2001, Weighing in on type 2 diabetes in the military: characteristics of U.S. military personnel at entry who develop type 2 diabetes, Diabetes Care, 24, 1894, 10.2337/diacare.24.11.1894 · doi:10.2337/diacare.24.11.1894
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-03-14
- Volume
- 36
- Issue
- 4
- Pages
- 1033-1046
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4229629337
- Cited by
- 2,163
- References
- 27
- FWCI
- 724.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.